Microbiology and Molecular Biology Reviews, December 1998, p. 1492-1553, Vol. 62, No. 4
1092-2172/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Posttranscriptional Control Group, Department of Biomolecular Sciences, University of Manchester Institute of Science and Technology (UMIST), Manchester M60 1QD, United Kingdom
SUMMARY
INTRODUCTION
CONCEPTS OF CONTROL IN GENE EXPRESSION
DELIVERING A FUNCTIONAL MRNA TO THE SITE OF TRANSLATION
YEAST TRANSLATION APPARATUS
Initiation Components
Binding of an active ternary complex to the ribosome.
Association of mRNA with the cap-binding complex.
Recruitment via the poly(A) tailan alternative route?
Selection of the translational start site.
Initiation of polypeptide synthesis.
Additional factors involved in translation.
Reaction pathways and kinetic control.
Translational Elongation and Termination
Elongation factors.
Release factors.
Sequence contexts and termination efficiency.
Analogous functions in prokaryotes and eukaryotes.
Termination need not be followed by ribosome release.
Mitochondrial Translation
PATHWAYS OF TRANSLATIONAL INITIATION
5'-End-Dependent Initiation
Principles of the scanning model.
(i) AUG context.
(ii) AUG priority rule.
(iii) Secondary structure blocks initiation.
Mechanisms relating translation rates to mRNA structure.
(i) Structure in the prokaryotic TIR.
(ii) Structure in the eukaryotic 5'UTR.
Mechanism of scanning.
Reinitiation
Prokaryotic reinitiation.
Eukaryotic reinitiation.
GCN4.
(i) There are essentially two types of uORF.
(ii) The spacing between sites of termination and initiation is critical.
(iii) Regulation is dependent on a fine balance between uORF types and intersite spacing.
(iv) Regulation of GCN2 kinase activity.
CPA1.
YAP1 and YAP2.
CLN3 and other examples of uORF-related control.
Internal Initiation in Yeast?
Alternative Coding Potential of Open Reading Frames
+1 frameshifting.
1 frameshifting.
Alternative decoding.
Protein splicing.
Prokaryotic and Eukaryotic Translation
Unresolved Issues of Quantitative Control
MECHANISMS OF TRANSLATIONAL REGULATION
Modulation of Translation Factor Activities
eIF4E.
4E-BPs.
eIF2.
Further gene-specific regulatory systems linked to Gcn4p activity.
Gene-Specific Regulation via trans-Acting Factors
Regulation via RNA-binding proteins.
Regulating the expression of dsRNA genomes.
Gene-specific regulation via antisense RNA in yeast?
CONTROL OF MRNA DECAY
cis-Acting mRNA Determinants
Stability determinants in the main ORF and 3'UTR.
Modulation of decay via the 5'UTR.
Termination in the 5'UTR.
Various structural features can influence mRNA stability.
trans-Acting Factors
Pathways of mRNA Decay
Role of deadenylation.
Other triggers of decay.
Regulation of mRNA Decay Rate
Back to Rate Control
CONCLUSIONS AND PERSPECTIVES
ACKNOWLEDGMENTS
REFERENCES
SUMMARY
|
|
|---|
Studies of the budding yeast Saccharomyces cerevisiae have greatly advanced our understanding of the posttranscriptional steps of eukaryotic gene expression. Given the wide range of experimental tools applicable to S. cerevisiae and the recent determination of its complete genomic sequence, many of the key challenges of the posttranscriptional control field can be tackled particularly effectively by using this organism. This article reviews the current knowledge of the cellular components and mechanisms related to translation and mRNA decay, with the emphasis on the molecular basis for rate control and gene regulation. Recent progress in characterizing translation factors and their protein-protein and RNA-protein interactions has been rapid. Against the background of a growing body of structural information, the review discusses the thermodynamic and kinetic principles that govern the translation process. As in prokaryotic systems, translational initiation is a key point of control. Modulation of the activities of translational initiation factors imposes global regulation in the cell, while structural features of particular 5' untranslated regions, such as upstream open reading frames and effector binding sites, allow for gene-specific regulation. Recent data have revealed many new details of the molecular mechanisms involved while providing insight into the functional overlaps and molecular networking that are apparently a key feature of evolving cellular systems. An overall picture of the mechanisms governing mRNA decay has only very recently begun to develop. The latest work has revealed new information about the mRNA decay pathways, the components of the mRNA degradation machinery, and the way in which these might relate to the translation apparatus. Overall, major challenges still to be addressed include the task of relating principles of posttranscriptional control to cellular compartmentalization and polysome structure and the role of molecular channelling in these highly complex expression systems.
INTRODUCTION
|
|
|---|
Much of the excitement in research on eukaryotic gene expression in recent years has been generated by work on the steps of this process that follow transcription. Taken literally, posttranscriptional gene expression includes all of the steps downstream of transcription that are involved in the realization of the coding potential of the genome, encompassing processes from mRNA modification and processing through to protein folding, sorting, transport, and turnover. However, this review focuses on the fate of pre-mRNA and mRNA during its path through the nucleus into the cytoplasm and its subsequent translation and degradation. In particular, research on the interactions between the translational apparatus and mRNA has uncovered many forms of posttranscriptional control. Moreover, it has become increasingly apparent that many of these different types of control are, in a number of ways, interdependent or coupled to each other.
The yeast Saccharomyces cerevisiae has played a key role as subject and/or host of increasing numbers of investigations in this area and remains a popular organism because of the ease with which it lends itself to genetic manipulation and analysis, in vivo phenotypic analysis, and biochemical experimentation. Moreover, the extensive nature of current knowledge of this relatively simple eukaryote, combined with the attention it is receiving from programs of intensive analysis at the genome, "transcriptome," and "proteome" levels (175, 176, 501, 571), places it first in line for achieving the status of being at least close to comprehensively characterized at some future date. All these points underline the importance of baker's yeast as an organism for study in an area of research like posttranscriptional control, offering, as it does, an increasingly complete picture of how the investigated mechanisms contribute to the physiology and growth of a whole organism. At the same time, it should be remembered that there are aspects of posttranscriptional gene expression that were exclusive discoveries of the yeast research community, including mRNA-specific translational stress responses, mRNA destabilization mediated by upstream open reading frames (uORFs), positive modulation of mitochondrial mRNAs via nucleus-encoded activator proteins, and autocatalytic protein splicing (all of which are discussed in this review).
This review explores the diversity of posttranscriptional control pathways in S. cerevisiae, focusing primarily on those currently known to be mediated or influenced by ribosome-mRNA interactions. Its content and structure reflect the philosophy that the processes of posttranscriptional gene expression should be considered components of a whole rather than being isolated systems. It has therefore been a general aim to examine the interrelationships between the mechanisms underlying posttranscriptional control and their thermodynamic and kinetic consequences at the molecular level. Given that control can be understood only in quantitative terms, the first section sets the stage by considering appropriate theoretical tools for handling control data. In the body of the review, comparisons with analogous prokaryotic and higher eukaryotic systems are made where these highlight key mechanistic principles. Since this review focuses on the issue of control, it does not attempt to serve as a comprehensive compendium of the literature on the cellular components involved. This has inevitably led to the omission of direct citations of many interesting papers, but the reader is encouraged to seek access to these via the cited reviews by other authors.
CONCEPTS OF CONTROL IN GENE EXPRESSION
|
|
|---|
The rapid development of techniques of molecular biology, biochemistry, genetics, and structural biology over the last few decades has resulted in an explosive increase in the rate of generation of descriptive information relating to cellular components. However, one of the major challenges of contemporary biology is the formulation of physiologically relevant models that describe how these components function in cellular processes. This depends on a successful transition from qualitative to more quantitative representation of living systems which, in turn, requires that biological mechanisms are increasingly described in terms of their thermodynamic and kinetic properties. However, this remains an uneasy interface between the disciplines of the physical and biological sciences, a problem that is exacerbated by the lack of conventions in the use of appropriate terminology. A prime example is the concept of kinetic control as applied to gene expression. As argued previously (361), there already exists a clear definition of control within the framework of metabolic control theory (276, 277), and this provides a suitable basis for unambiguous terminology that can be used to describe posttranscriptional events. This also allows the term regulation to be used in a consistent and unambiguous manner.
Two types of approach to the description and analysis of gene expression pathways will be considered briefly in this review. They offer complementary views that can both be helpful in planning and evaluating quantitative experiments. The systemic approach to metabolic control analysis described by Kacser and Burns (276, 277) was conceived as a means of analyzing complex multienzyme systems which are generally too complex to be amenable to accurate analysis by standard kinetic descriptions of the component reactions. This approach can be usefully applied to the partially processive reactions of pathways such as translation, and some of the concepts are introduced here so that the corresponding terminology can be used later in this review without causing confusion.
The key conceptual tools of the analysis are the coefficients used to
define "control" in such a complex system. The most relevant of
these in the present context is the control coefficient. This describes
the relationship between the activity of each catalytic component
(E) and the resulting effect on the flux. The activity variation of each E could be caused by a change in
concentration, modulation of its kinetic properties, or the binding of
an effector. Each change in a given E component (enzyme) can
be expressed as a fractional change,
Ei/Ei, and this is reflected in a
shift to a new steady-state flux, expressed as
F/F. The
ratio of the latter to the former represents a measure of the
effectiveness of the imposed change in altering the flux, and under the
condition
Ei
0 it represents a definitive
property of the system, called the control coefficient:
Zi = d ln F/d ln
Ei. Zi can theoretically assume any
value between 1 and 0: a value near 1 means that
Ei has a very strong controlling influence on
the overall flux of the system, whereas a value near 0 corresponds to a
comparatively minimal contribution to control and probably applies
frequently to components of gene expression pathways. An important
constraint defined by the Kacser and Burns analysis is the summation
principle, which states that the sum of the Zi
values must equal 1. Most importantly, this type of analysis emphasizes
that control is distributed among the respective
Eis, with the relative individual contributions
being reflected in their respective Zi values.
Accordingly, the use of the term "rate-limiting" for any chosen
step or Ei in the vast majority of living
systems is likely to be misleading and can be meaningless. The
Zi values are determined by a range of factors;
in a multienzyme pathway, for example, these factors include the
distance of each enzyme from substrate saturation, enzyme
concentration, the relationship between the mass-action ratio and the
equilibrium constant for each step, and the role of effectors.
Analogous properties of the gene expression pathway also contribute to
an equivalent set of Zi values. Unless
exceptional forces are at play, there is likely to be selection
pressure on a cellular pathway to evolve toward a system in which the
Zi values are not excessively unequal. For
example, the provision of certain catalytic components in great excess
of their required operational capacities generally makes little sense
in terms of cellular energetic housekeeping. Whatever the pathway, this
treatment tells us that estimates of Zi for the
respective components are required so that we can model the balance of control.
The above summary of key points intrinsic to the systemic analysis of multienzyme pathways can be seen as a stepping stone to a more consistent theoretical approach to the even more complex pathways involved in gene expression. As will become apparent, although the transition is not entirely straightforward because of the processive nature of at least some of the reactions, the concepts and terminology are useful for even relatively qualitative descriptions of the pathways under examination. For convenience, this review continues to use the term "control" in its generally accepted sense to describe the factors determining the (constitutive) rates of biological processes. However, when applied in discussions of the kinetic details of specific pathways, "control" is applied in the sense explained above and is not intended to imply exclusive rate-limitation by any given step or entity.
The systemic type of model contrasts with the more conventional approximations of pathway kinetics based on several assumptions regarding sites of strong controlling influence (see, for example, references 173, 339, and 340). This second approach is discussed in connection with the specific posttranscriptional pathways as these are addressed in the review. As will become apparent, the latter type of model for a partially processive pathway can be regarded as a special case of the more general approach, but the assumptions on which it is based require careful scrutiny.
DELIVERING A FUNCTIONAL MRNA TO THE SITE OF TRANSLATION
|
|
|---|
One of the least well understood areas of gene expression is how polymerase II (PolII) transcripts are transported from the sites of their synthesis in the nucleus to the sites where they are translated (Fig. 1) (see, for example, reference 404). The significance of this problem in terms of posttranscriptional control can be seen in a number of ways. First, the rate of export to the cytoplasm influences the steady-state availability of translatable mRNA. Second, pre-mRNA and mRNA interact with a range of splicing components and/or heterogeneous nuclear ribonucleoproteins (hnRNPs) (141, 581), most of which have to be effectively replaced at some stage by ribosomes and translation factors in the cytoplasm if translation is to occur. Some hnRNPs shuttle between the nucleus and the cytoplasm (439), and these might be of particular importance to the architecture and translation of the cytoplasmic mRNPs (596). Third, mRNA export and translation may occur simultaneously, possibly with vectorial and energetic consequences for the export process.
|
Of these three points, the first two remain at an early stage of characterization and provide us with only a few hints about potential sites of posttranscriptional control on mRNA transport. It is generally agreed that, with very few exceptions, only mature mRNAs (bound by RNA-binding proteins [mRNPs]) leave the nucleus (254, 255). A key feature in this respect is the 5' cap structure. PolII transcripts are capped with methylated terminal structures (516), comprising in S. cerevisiae either m7G(5')pppAp (relative frequency, 75%) or m7G(5')pppGp (25%). Cap methylation is essential for cell viability (351). The cap promotes mRNA export (198), although experiments with an S. cerevisiae strain containing a temperature-sensitive capping enzyme (Ceg1p, which transfers GMP from GTP to the 5' end of the mRNA) indicate that the cap is not essential for splicing, polyadenylation, or transport (158, 493). In another study, a hammerhead ribozyme was used to catalyze in cis cleavage of a fusion mRNA in S. cerevisiae (144). The capless downstream product was undetectable by standard blotting techniques, as would be expected if the cap is important for nuclear export and/or stability. From the above-mentioned work on CEG1 mutants (158, 493) and further studies described in the section on mRNA stability in this review, it would now seem that the cap influences stability more than transport. At least for histone mRNA, 3' end formation also stimulates the transport process (143).
A heterodimeric nuclear m7G cap-binding complex (CBC), comprising two cap-binding proteins (CBP20 and CBP80), has been identified (256), but its role is unclear and it is not essential in yeast (404). In a wider context, discussions about whether nuclear mRNA moves through a "track" (461, 601) or via "channelled diffusion" (612) and discussions about the interactions between mRNA and various nuclear components, including the nucleoskeleton (47), spliceosome components (237, 324, 511, 614, 615), nucleolus (537) and nuclear membrane and/or pore complexes (238), all of which could theoretically influence the transport process, are still under way. To what degree the gene expression processes in the nucleoplasm are structurally or functionally compartmentalized is controversial (505).
The third point raises the issue of how mRNAs find their way to translationally competent ribosomes. Perhaps the most relevant data have come from studies of the Balbiani ring granule, a large RNP particle, in the dipteran Chironomus tentans (367). These results indicate that the particle generally exits the nucleus 5'-end first and is bound by ribosomes before the 3' end passes through the nuclear pore. However, there is no evidence that mRNA export per se requires translation (41). Studies of S. cerevisiae continue to yield new clues about the process of mRNA export. For example, recent evidence indicates that the ATP-dependent RNA helicase Dbp5p, which is a DEAD-box protein closely related to eIF4A, is involved in mRNA export through the nuclear pore complexes (507a, 552a).
While translatable mRNAs are undoubtedly generated primarily by PolII promoters, there is evidence that the pathway outlined above is not the only possible route from nuclear gene to cytoplasmic protein in the eukaryotic cell. Notable in this context is the demonstration that the PolIII promoter of the adenovirus type 2 VA RNAI gene generates uncapped and nonpolyadenylated RNA, which is nevertheless translated, albeit poorly, in HeLa cells (191). This indicates that capping and polyadenylation are not essential for nuclear transport or translation, although it has yet to be determined whether the route taken by such PolIII transcripts may allow them to escape restrictions otherwise imposed on their PolII counterparts. Similarly, it has since been shown that in S. cerevisiae, HIS4 can be transcribed from a PolI promoter to generate primarily uncapped but polyadenylated mRNAs that are poorly translated and rapidly degraded (338a). Overall, these data are in accord with a theme that threads its way through a number of the processes of gene expression: redundancy of function and/or parallel routes provide alternatives for many key steps. What therefore appears to be a major pathway may not be dictated by fixed mechanistic limitations but, rather, may be guided by kinetic or thermodynamic principles of control.
It is clear from the above that there remains considerable uncertainty about the role of any of the nuclear events in posttranscriptional control. Looking beyond the nuclear membrane, there are various lines of evidence for selective distribution of exported mRNA to specific sites within a cell (129, 504, 594) or within whole organisms, for example in Drosophila embryos (504, 589). The fact that mRNA is observed associated with microtubules and actin filaments suggests that these components of the cytoskeleton may be responsible for (selective) mRNA transport (35a). In higher eukaryotes, mRNA partitioning is involved in developmental processes including the establishment of cell polarity and morphogenesis (118, 196, 288) and in the response to signals from the cell surface (89a). Recent evidence also indicates that at least one yeast mRNA (ASH1) becomes localized within the cell by virtue of its association with the cytoskeleton (535). The 3' untranslated region (3'UTR) of this mRNA is necessary for its transport to the distal tip of daughter buds in postanaphase cells. To what extent mRNA sorting plays a role in the yeast cell cycle remains to be established.
Posttranscriptional gene expression begins with a nascent transcript, which goes through a highly complex series of nuclear interactions before emerging into the cytoplasm. However, each transcript is much more than simply an intermediate carrier of genomic coding sequences. A single mRNA can contain several different types of signal element that contribute to one or more forms of posttranscriptional control (Fig. 2). The 5'- and 3'-terminal modifications have a number of general functions that affect the whole mRNA pool. Apart from its role in nuclear export (198), the cap is required for efficient translation (471, 484) and also influences mRNA stability (162), although the extent to which each function overlaps with the others remains unclear. At the 3' end, the mRNA carries a poly(A) tail (initially 60 to 90 adenylate residues in yeast [186, 472]), which also influences the cytoplasmic expression and fate of yeast mRNAs (264, 476). The functions of the untranslated, flanking regions of yeast mRNAs have come under increasing scrutiny in recent years since they, unlike the mRNA modifications, can contain a number of signals that modulate the expression of specific genes in individual ways. Finally, the main reading frame of the mRNA not only constitutes a decodable codon sequence, but also can contain further information in the form of linear signals or conformational blueprints that influence posttranscriptional gene expression, although little is known about them at present. Overall, mRNA carries much more information than merely its coding sequence. The central challenge is understanding how this additional information is able to exert its influence via interactions with the cellular machineries responsible for translation and mRNA turnover.
|
YEAST TRANSLATION APPARATUS
|
|
|---|
Review articles dealing with the cellular translation apparatus have appeared very recently for mammalian cells (369, 418, 508) and plants (69, 166) and somewhat less recently for yeast (228, 332, 553), and the reader is directed to these reviews for more detailed information about the individual components of the respective systems. In this section I focus on the properties of yeast translation that have most relevance to the known posttranscriptional control mechanisms and how the latest research has shaped the current view of them. The primary pathway of translation in S. cerevisiae is initiated via a cap-dependent mechanism that seems to follow broadly the main pathway that has been delineated on the basis of biochemical studies with mammalian cell extracts. Initiation is not only the most complex step of translation but also a major site for regulation of individual and global gene expression at this level. The subsequent elongation and termination of the polypeptide chain also follow the same general pattern seen in mammalian cells. The overall similarities between the translation machineries of the higher and lower eukaryotes offer the advantage that results gained with both types of system contribute to a general eukaryotic picture of translation. Nevertheless, yeast translation is by no means a carbon copy of its higher eukaryote counterpart, and the increasingly apparent greater or smaller differences between the respective systems can provide additional insight into the structural basis for specific functions in this process. In the following, "yeast translation" refers to protein synthesis in the cytoplasm. However, it should not be forgotten that a very small proportion of yeast proteins are synthesized in the mitochondria.
Before moving on to describe the yeast translational apparatus in more detail, it is useful to consider how the three stages of translation are kinetically related to each other (Fig. 3). Their respective kinetic characteristics are relevant to the functions of the individual components of the translation apparatus; the potential contributions of initiation, elongation, and termination to the control of flux through the whole system; and the interdependency of these three phases. A striking aspect of eukaryotic translation is the processive nature of the events occurring after initiation and the at least partly processive nature of the initiation phase. This has consequences for the ways in which rate control can be exercised on translation (Fig. 3).
|
For example, there are kinetic arguments why initiation can be expected
to figure so prominently in terms of posttranscriptional control. Given
certain apparently reasonable assumptions, it is relatively easy to
arrive at a simplified (nonrigorous) model of the translation pathway
(Fig. 3). This scheme summarizes some basic principles concerning
potential control points in the protein synthesis pathway. For the sake
of simplicity, the steps of translation are represented by flow rates
(j values, as defined in Fig. 3). It is assumed that
the rate of release of 40S ribosomal subunits from the mRNA during the
scanning phase is negligible and that the scanning rate itself is
relatively high. The maximal attainable rate of initiation of protein
synthesis is dictated by the time taken for the 80S ribosome to clear
the AUG region, making space for the next approaching 40S subunit. The
region blocked by one ribosome is approximately 30 nucleotides
(597); therefore,
jI
jE/30. The
jE term used here may be adequately described as
an average elongation term, but at least in certain mRNAs it may have
to be qualified as referring to only part of the open reading frame (ORF). There is evidence that pausing occurs within eukaryotic reading
frames, causing ribosomes to "stack," at least in certain regions
of the mRNA (597). If termination of protein synthesis (jT) were to proceed at a much lower rate than
initiation (jI), there would be a blockage that
would feed back from the 3' end of the ORF, distorting the structure of
polysomes. This is not known to happen (49), but there is
evidence for a pause near the termination codon (597), and
so it would seem reasonable to assume that for an mRNA with an
unstructured leader, jT
jI. The
scanning component of jB is unlikely to be slow
compared to jI on unstructured leaders, since
this would result in a high loading density of 40S subunits on the
5'UTRs of all mRNAs, for which there is no evidence. Given that pausing
seems to occur at the start codon (232, 260, 296, 597), we
can assume that jB
jI for an
unstructured leader. However, the jB term will be greatly reduced in the presence of structure, thus changing this
relationship to jB < jI. The above
set of principles and assumptions yields a model in which the
individual steps of protein synthesis are well matched, allowing the
most efficient throughput of ribosomes on an mRNA molecule.
It should be pointed out, however, that while restrictions on jB, jI, or jT can seriously disturb this balance, changes in jE (at least over a certain range) can be more readily accommodated. In other words, applying the terminology of the Kacser and Burns (276, 277) approach to this processive series of reactions, the control coefficient for elongation is considerably smaller than for the other reactions. A low average rate of elongation (jE1 [Fig. 3B]) may not greatly affect the relative rate of production of complete polypeptide chains on a specific mRNA unless it results in restricted access to initiating ribosomes (jI). Increasing the rate of elongation (jE2 [Fig. 3C]) will also have no effect on the number of polypeptide chains completed in unit time under steady-state conditions unless jI (and/or jT) changes. The major difference between the cases in Fig. 3B and C in the steady state will therefore be the density of ribosomal binding. This, in turn, will influence primarily the number of ribosomes bound up in the process of protein synthesis at any one time and hence the availability of free ribosomal subunits in the cellular pool. Where the rate of elongation on individual mRNAs is modulated, for example via the internal nucleotide sequence (codon usage), the impact on the cellular ribosome pool will be negligible, so that the overall steady-state rate of polypeptide production will be relatively unresponsive. Finally, one way of maintaining tight control over the efficiency of the overall process would be to couple termination and initiation, as might occur in the closed-loop model of polysome structure (Fig. 3D).
These are the chief theoretical constraints required to explain how initiation can feature as a step with strong controlling influence (a large control coefficient). The processive nature of elongation means that translation can be represented by a simplified model in which the elongation process is viewed as a single step (i.e., elongation is represented by simply jE [Fig. 3]). This and other assumptions result in a greatly simplified treatment, which has formed the basis for previous analyses of eukaryotic translation (see, for example, references 173, 339, and 340). One of the questions raised by these analyses is whether the modus of rate control leads to differential attenuation of the translation of individual mRNAs upon shifting a cell from good growth conditions to more restrictive ones. If it is assumed that the poor translation of an mRNA carrying stable secondary structure or a uORF in its leader is based on poor selection of that mRNA by the ribosome, it might be expected that the shift from saturating or near-saturating activity of the translational apparatus to a reduced capacity will affect the poorly translatable mRNAs more severely. However, as discussed below, it is not clear whether selection of an mRNA (i.e., the initial step[s] of initiation) is affected by the structural elements located in the leader. Thus, while the semirigorous analyses reviewed so far bring the issue of control into focus, they do not yet enable us to model translation adequately. This point will be revisited once further information on the translation pathway has been considered.
Initiation Components
As discussed later in this review, eukaryotic translational initiation can occur in at least three ways on cellular mRNAs. By far the most common route is the 5'-end-dependent pathway, in which ribosomes apparently select the initiation site via processive scanning along the 5' region of the mRNA. The most striking aspect of the cellular system involved in this pathway is the number and complexity of its components. Apart from the subunits of the eukaryotic ribosome, there are at least 11 eukaryotic initiation factors (eIFs) comprising more than 25 polypeptides (369). These are presented in Table 1. Unfortunately, the disparities between the genetic nomenclatures for the respective organisms makes this subject area highly confusing for the non-specialist. One potential solution would be to adopt a new systematic nomenclature that is related in a readily deducible fashion to the biochemical designations. A proposal of this nature has been made for Schizosaccharomyces pombe which could easily be applied generally (Table 1) (334). Of the yeast initiation factors identified so far, eIF4A, eIF4G, and eIF5A have been found to be encoded by duplicated genes. Like many other duplicated genes in S. cerevisiae, they are at least partially phenotypically redundant (180, 333). Indeed, the eIF4A products are identical. It has been suggested that the maintenance of at least some duplicated genes may reflect past adaptation of the organism to a changing environment (595), but to what extent this type of selective pressure is directly applicable to the initiation factor genes is unknown.
|
Given the complexity of the initiation process, it has inevitably been easier to characterize partial reactions, each involving a subset of the total pool of eIFs, than to piece together the whole puzzle. The current picture of the pathway derives primarily from experimental work performed on mammalian proteins. The pathway depicted in Fig. 4 has been adapted to take into account the differences so far identified in the yeast system. This undoubtedly simplified version of the real process considers four steps: (i) binding of an active ternary complex to the ribosome; (ii) association of mRNA with the cap-binding complex; (iii) selection of the translational start site; and (iv) initiation of polypeptide synthesis. These steps are discussed in detail below.
|
Binding of an active ternary complex to the ribosome.
eIF2 is a heterotrimeric complex that is required for the binding
of Met-tRNAi and mRNA to ribosomes in vitro. The
GTP-charged form of eIF2, which binds Met-tRNAi in vitro to
form the 5S ternary complex, is generated in an exchange reaction
catalyzed by eIF2B (45, 480). There is also evidence
suggesting that eIF2B promotes the cycling of eIF2-GDP off the ribosome
during the initiation process (423a). The component subunits
of eIF2 (
,
, and
) are all essential for cell viability, and
mutations in them affect start codon selection by the ribosome
(93, 185, 369). Moreover, Cigan et al. (93) also
used mutations in the anticodon of one of the four tRNAi
genes in S. cerevisiae to establish the key role of
tRNAi-start codon interactions in initiation site
selection. Appropriate compensatory mutations in the anticodon allowed
initiation on the HIS4 reading frame by using non-AUG codons
that would otherwise not be recognized by the preinitiation complex.
The order of the interactions between eIF2-GTP-Met-tRNAi,
the ribosome, and the mRNA is not fully resolved. The bulk of the
available in vitro data points to 40S-ternary-complex binding
preceding mRNA binding, but Trachsel discusses conditions where this
might not apply (552). Certainly, the phenomenon of
reinitiation constitutes evidence that close association of 40S
subunits and mRNA can occur in vivo before the binding of the ternary
complex, at least downstream of a termination event (see below).
Finally, earlier this year there was an exciting development in this
area. S. cerevisiae was found to possess a homologue of
E. coli IF2, called yIF2 (89b). The encoding
gene, FUN12, is not essential, but its deletion imposes a
severe slow-growth phenotype and a marked translation initiation defect. Biochemical experiments indicate that yIF2, like eIF2, functions to promote Met-tRNAi binding to the 40S ribosomal
subunit (89b). The tantalizing question yet to be resolved
is why S. cerevisiae uses both yIF2 and eIF2; does this
represent an intermediate stage in ongoing evolution of the translation
system in this organism, or are there particular reasons for the
maintenance of these parallel functions?
Association of mRNA with the cap-binding complex. eIF4E is the cap-binding component of the initiation factor complex eIF4F, anchoring this complex to the 5' end of capped mRNAs. It is the least variable of the eIF4F components (in terms of presence in the complex and/or protein sequence) and one of the less abundant eIFs (estimated to be present at levels greatly substoichiometric with respect to those of the ribosome [see below]). eIF4E is required for efficient translational initiation in vitro (11), and it is thought that it fulfills the same functional role within the assembled eIF4F complex in vivo. In mammalian eIF4F, eIF4E is associated with two other factors, eIF4G and eIF4A, whereby eIF4G holds the respective factors together in the complex (Fig. 5). Recent reports (121, 168) describe a second human eIF4G gene (encoding eIF4GII), which is 46% identical to the initially cloned gene (eIF4GI [605]) (Fig. 5), and also a second human eIF4E gene, which encodes a protein differing at only two positions. eIF4GII is likely to be a functional homologue of eIF4GI, and there is speculation that the different forms of this protein may be required for a differentiated response to developmental signals (181). The second eIF4E species is likely to be fully functional, and the reason for the duplication has yet to be ascertained. On the other hand, a human protein (4E homologous protein [4EHP]), with 30% identity to eIF4E, has also been described, but as yet it has no apparent function (460a).
|
9 [449]). However, two other entities,
a protein called p20 and the poly(A)-binding protein Pab1p, are also
found associated with the eIF4F components of S. cerevisiae;
p20 competes with eIF4G for binding to eIF4E, and Pab1p binds to eIF4F
via a site on eIF4G (10, 15, 539). Moreover, other
interactions are also suspected to occur at least transiently (see the
sections on eIF4A and eIF4B below). eIF4G also occurs in two forms in
S. cerevisiae, eIF4G1 and eIF4G2, and the former type (p150)
is larger than the latter (p130) (180) (Fig. 5).
Mammalian eIF4G is much larger than its yeast homologues and has
binding sites for eIF4E, eIF3, and eIF4A (312, 346). It is
therefore appealing to regard eIF4G as a sort of docking protein or
adapter (214, 312, 383, 479, 509) for the assembly of the
complex between mRNA and the preinitiation complex. There is also a
further family of eIF4G-like proteins in mammalian systems. For
example, one of them, p97, shows 28% identity to the C-terminal two-thirds of eIF4G and thus apparently lacks an eIF4E-binding site
(243). Other versions of this 97-kDa protein have been
isolated from various sources (see the summary in reference
383). p97 may act as a translational repressor by
forming translationally inactive complexes with eIF4A and eIF3,
although other properties of this protein may be involved
(383). In this context, it should be noted that mammalian
eIF4G can be cleaved by viral proteases (e.g., protease L of poliovirus
or protease 2A of foot-and-mouth disease virus) to leave a C-terminal
product lacking the eIF4E-binding domain (312, 409). The
resulting C-domain can support cap-independent or internal ribosome
entry site (IRES)-dependent translation in vitro (409). One
of the known plant eIF4G factors, p86, is considerably smaller than the
other known eIF4G proteins (6, 68, 373). This protein, also
known as eIFiso-4G, seems to be lacking much of the N-terminal domain
present in its yeast and mammalian counterparts (Fig. 5). It is found
associated with eIFiso-4E in the alternative plant complex referred to
as eIFiso-4F (68, 373). Despite the inclusion of the much
smaller version of eIF4G, the latter complex is functionally equivalent
to eIF4F in a range of in vitro assays (320, 373). The other
plant eIF4G protein, p220, has yet to be fully characterized
(69).
It is not known in which order the eIF4F-mRNA complex is assembled in
vivo, nor is the potential functional significance of any given order
fully clear. However, the occurrence of cooperativity effects (see
later in this section) is likely to dictate a preferred route for the
formation of a cap-associated complex. Moreover, the association of
eIF4E with eIF4G can be at least partially blocked by the binding of
eIF4E-binding proteins (4E-BPs) (421). In S. cerevisiae, there is currently only one candidate for this role,
p20 (10, 315), which in fact has a molecular mass of approximately 18 kDa (613). Whether p20 constitutes the full yeast equivalent of a mammalian 4E-BP is discussed in the section on
translational regulation (see below).
The X-ray structure of an N-terminal truncated form (amino acids 28 to
217) of mouse eIF4E has recently been determined at 2.2-Å resolution
(354). The structure correlates well with previous genetic
and biochemical data and also provides the basis for a number of
important predictions. It is therefore worthwhile considering certain
of its details at this point. Since the truncated mouse protein still
binds the cap analogue 7-methyl-GDP and since an equivalent
N-terminally truncated form of S. cerevisiae eIF4E (amino
acids 30 to 213) has been shown to support growth in an otherwise
eIF4E-deficient strain of yeast (569), it is clear that the
N-terminal region is not essential for the maintenance of (at least
partial) structure and function by the eIF4E protein. The determined
structure comprises one domain with an overall shape resembling a
cupped hand. Within this domain there is an eight-stranded antiparallel
-sheet, three long
-helices, and one short
-helix. The short
-helix and the concave surface of the
-sheet form the cap-binding
slot. Of particular interest are the locations of a number of the
residues that are conserved between the various eIF4E sequences that
have been sequenced so far (Fig. 6). The
methylated base of the cap analogue fits between the tryptophan
residues at positions 56 and 102, and the interaction is most likely
driven by
-
stacking enthalpy as predicted previously by Ishida
et al. (246-248; see also reference
9). Apart from these stacking interactions, there
are hydrogen bonds or van der Waals contacts between the methylated G
of the cap and Trp102, Glu103, and Trp166; direct interactions between
the ribose and diphosphate groups of the cap structure and Trp56,
Arg157, and Lys162; and water-mediated contacts with Trp166 and Arg112.
All of these residues are either fully conserved or subject to only
conservative changes between the respective eIF4E species (Fig. 6). The
results of mutational studies on a number of these residues in the
yeast and human eIF4E proteins, in particular the tryptophans, have generally been consistent with their playing a role in cap binding (9, 382).
|
-strands
and one
-helix are shorter in the yeast protein, and Trp58 in the
cap-binding site has a different orientation from that of its mouse
counterpart. Matsuo et al. (358) also described a complex
between yeast eIF4E and mammalian 4E-BP2 and showed that the NMR
resonances were particularly perturbed in yeast eIF4E at amino acid
positions 32 to 50 and 62 to 79, although the resonances of 13 further
amino acids in the region 85 to 169 were also affected. At least some
of these are surface residues, and it will now be necessary to
establish whether any of them participate directly in 4E-BP binding.
More recent work has combined classical genetic, immunological, and
biochemical methods with surface plasmon resonance analysis to obtain
information about the residues in yeast eIF4E that contribute to or
influence the binding sites for eIF4G and p20 (449).
Mutations at HPL37-39, W75, E72, V71, and G139 were found to decrease
the affinity of eIF4E for a recombinant protein bearing the
eIF4E-binding domain of eIF4G. These residues are all highly conserved
among the eIF4E proteins sequenced so far and map to a cluster on eIF4E that is located on the dorsal side of the structure relative to the
cap-binding slot (Fig. 7). It is,
however, striking that the binding site for p20 overlaps but is not
identical to that of eIF4G (Fig. 7).
|
|
Recruitment via the poly(A) tail
an alternative route?
Recent work has shown that S. cerevisiae eIF4G1 and
eIF4G2 also have N-terminal binding sites for the poly(A)-binding
protein (539, 541) (Fig. 5). This and other observations
(165, 167, 320, 392) have revitalized the debate about the
roles of the poly(A) tail and the poly(A)-binding protein in
translation (see, for example, the recent review of this theme by
Jacobson [264]). Speculation about possible
"long-range" interactions between Pab1p and the ribosome had
already been stimulated by the isolation of pab1 suppressor
strains that harbored mutations in genes encoding 60S subunit proteins
(474). Moreover, as discussed below, there is in vitro
evidence that the poly(A) tail participates in the recruitment of
ribosomes onto mRNAs via a pathway that can function independently of
the cap. Investigations in vivo (445, 446, 541), however,
paint a more complex picture (see below). The poly(A)-binding protein
of higher and lower eukaryotes has four RNA recognition motifs. These
contribute to differing degrees to poly(A)-specific and
non-poly(A)-specific RNA binding (72, 114, 306, 403, 478).
The second RNA recognition motif of Pab1p is required for binding to
eIF4G in S. cerevisiae (284), but the actual site
has yet to be defined. Most remarkable is the conclusion from
mutagenesis studies that Pab1p does not require its specificity for
poly(A) to perform functions necessary for cell viability
(114). Moreover, while Pab1p binding is shared by wheat
eIF-iso4G (320), it has not been clear whether it is also
evident in human eIF4GI/II or S. pombe eIF4G (181,
383). There is, however, now agreement that in the former case
the site was originally overlooked because of uncertainties about the
N-terminal sequence of human eIF4G (509a). Continuing work
on S. pombe eIF4G should also resolve uncertainty about
Pab1p binding for this fission yeast (449a). A further study
has now complicated the story somewhat, since a 480-amino-acid human
poly(A)-binding protein (PABP) which shows similarity to the central
region of eIF4G has been described (102). The results of
continuing investigations of these various Pab1p-related proteins and
interactions are awaited with interest.
Selection of the translational start site. The prokaryotic ribosome can locate a start codon via direct interactions with sequence elements such as the Shine-Dalgarno region located within a translational initiation region (TIR) that has evolved to guide and modulate the initiation process (177, 178, 362, 363). In contrast, despite the theoretical proposition that "translation-initiation promotion sites" may enhance the expression of certain genes (545), there is no experimental evidence for such rRNA-mRNA interactions mediating start site selection in the eukaryotic cell. Instead, initiation on the vast majority of cellular mRNAs involves a process currently modelled by the "scanning hypothesis" (to be considered in more detail below). Investigations of mammalian in vitro systems have indicated that the process of scanning through structural leader regions to the start codon may be driven by the helicase activity of eIF4A (which is enhanced in association with eIF4B), possibly associated with the small ribosomal subunit (509). eIF4A belongs to the DEAD-box family of proteins, which possess ATPase and ATP-dependent RNA helicase activities (161, 487). It is required for translation in a yeast cell extract (57). However, it is not included in the eIF4F complex isolated from S. cerevisiae, and it is therefore questionable whether it cycles through the yeast eIF4F complex, as has been suggested for the mammalian protein (420). On the other hand, it seems unlikely that the function of eIF4A is linked solely to its potential role in destabilizing secondary structure in the 5'UTR, since in the experiments of Blum et al. (57) it was required for the translation of an mRNA that had a relatively short, unstructured leader. Overall, the role of the RNA helicase activity of eIF4A and eIF4B in scanning remains poorly defined.
Scanning continues until the preinitiation complex has selected an AUG codon. In the apparent absence of an equivalent to the prokaryotic rRNA-Shine-Dalgarno (SD) region interaction, AUG selection by the eukaryotic ribosome is directed by the anticodon-codon specificity of Met-tRNAi (93). It is known that the selection process involves participation of eIF2, since mutations in this factor can alter the specificity of the codon selection process (135, 236). Moreover, very recent work by the Donahue group suggests an unexpected role for eIF5 in determining the stringency of AUG selection (236). It seems that eIF5 acts to control the fidelity of the AUG selection process (there is a functional analogy here to the role of prokaryotic IF3). A mutant form of eIF5 was found to allow recognition of UUG as a start codon in vivo and to enhance GTP hydrolysis on the 43S preinitiation complex in vitro (236). It was proposed that an abnormal eIF5 can promote GTP hydrolysis, thus triggering release of eIF2-GDP (plus other initiation factors [Fig. 4]) at a non-AUG codon. This is then thought to allow the ribosome to recognize the non-AUG codon as a start site, effectively switching it into the polypeptide initiation mode. The
subunit of eIF2 carries a
binding site for eIF5, suggesting that the above functions involve
direct interactions between the two factors (112a).
Initiation of polypeptide synthesis. Once the 40S subunit has located a start codon, the 60S subunit joins it to form the 80S initiation complex, which can then begin with peptide bond formation between the initial methionine and the second encoded amino acid. This ribosome-joining step is promoted by eIF5, which, as we have seen, acts to ensure the fidelity of the Met-tRNAi-start codon interaction (85, 236, 369). A number of other factors are likely to be released at this point. Of particular interest is the dissociation of eIF2, which is now complexed with GDP after hydrolysis of the GTP that was originally bound and which will have to be recycled back to the GTP form by eIF2B in preparation for a further round of initiation. The mechanism of this GDP-GTP exchange reaction is still the subject of lively discussion (552).
Additional factors involved in translation. There is quite a collection of proteins that, like Pab1p, seem to be involved in, or influence, the initiation process but are not formally classified as eIFs. This is something of a grey area in terms of formal classification, but it may also be indicative of important but as yet uncharacterized functional interactions between the translational apparatus and other cellular components. For example, Donahue and colleagues (190, 609) isolated four unlinked genes (SSL1 to SSL4) which, when mutated, can suppress the inhibitory effect of a stem-loop structure in the 5'UTR of HIS4. SSL1 and SSL2 were more recently determined to encode components of the transcription factor TFIIH (578). SSL2 was also found to be a yeast homologue of the human ERCC-3 gene, thought to be involved in DNA repair (190). It is still unclear to what extent the observed effects of the SSL mutants on translation reflect the normal roles of these genes in wild-type cells. SIS1, which encodes a yeast homologue of Escherichia coli DnaJ, has also been linked to translation (617). The temperature-sensitive phenotype of a SIS1 mutant was suppressed by one of the ribosomal gene deletion mutants that was previously shown to suppress a pab1 mutant (474). Again, while links between translation and other cellular processes are suggested, the mechanism underlying this effect remains unknown. It is interesting that the theme of chaperones apparently influencing translation is also evident in the phenotypes of mutations in two genes encoding 70-kDa heat shock proteins (hsp70s), i.e., SSB1 and SSB2. In this case however, the translation defect was suppressed by overexpression of the HBS1 gene, which encodes a protein resembling eIF1A and eRF3 (401). The Ssb proteins may be core components of the translating ribosome, perhaps preventing misfolding of nascent polypeptide chains (436a). Finally, one additional factor has been found that seems to be required for translation in wild-type yeast cells (91, 119). This is Ded1p, which is a DEAD-box protein originally identified as a potential suppressor of defects in pre-mRNA splicing (269) and PolIII (549). Ded1p is required for translational initiation in vitro (91), and ded1 mutants are defective in translational initiation (91, 119).
The above examples of gene products that can apparently influence translation might be telling us that the cellular translational apparatus is not adequately defined in terms of the formally classified translation factors alone. They can also be interpreted in terms of the view that functional overlaps are an essential feature of molecular evolution, so that it would be inadvisable to apply excessively rigid definitions of what might constitute "true" translational components. In this context, it is worthwhile to consider how a family of proteins, such as that sharing the DEAD-box motifs, can be involved in a range of processes associated with RNA (161, 487). Indeed, the protein encoded by FAL1 in S. cerevisiae has 55% amino acid sequence identity and 73% similarity to eIF4A but is active in pre-rRNA processing rather than translation (303). These observations raise the question whether eIF4A itself may be inadequately defined as "merely" a translation factor and whether, in a wider context, an unknown number of the other proteins currently classified as translation factors are fully "dedicated" components of the translational apparatus. Further research should reveal how the DEAD-box-type motifs can be combined with a variety of other protein domain structures to confer different functional roles on the members of this family.Reaction pathways and kinetic control. While it is convenient to break down the initiation process into distinct steps, there is in fact little information on the spatial and temporal relationships between the respective partial reactions within the living cell. For example, the translational apparatus can hardly be envisaged as a farrago of randomly acting components, but is there a highly ordered multifactor supercomplex (a "translatosome"), or does the reality lie somewhere between these two possible extremes? It is impossible to resolve issues such as this on the basis of in vitro experiments alone, since disruption of the complex and delicate pathways in the cell may leave only partially or completely uncoupled component reactions. Effectively torn out of its natural cellular environment, translation in vitro is likely to reflect, but unlikely to reproduce, the bona fide process in vivo. This problem may be particularly applicable to the initiation step, since this encompasses not only the transition from the nuclear phase of the life of an mRNA to its recruitment by the translational machinery but also the orchestration of the most complex phase in protein synthesis. Also linked to this problem is the fact that initiation is not an autonomous process occurring independently of the other phases of translation. Statistically, it would be expected that most ribosomes initiating protein synthesis on an mRNA had recycled after previously terminating at least one other polypeptide chain. In general, this means that the pool of ribosomes available for initiation is subject to control by the termination process and posttermination events. Moreover, there are theoretically two extreme cases where this control might be exercised within the confines of a single polysome: as a consequence of reinitiation on a multicistronic mRNA (see below), and in the context of a "closed-loop" (265) type of polysome structure which might allow a ribosome terminating at the 3' end of the mRNA to be recycled back to the 5' end (see, for example, reference 233) or to influence de novo initiation at the 5' end. Reinitiation is known to occur (see below), while the latter type of mechanism is feasible but has not been confirmed as a potential pathway. These considerations emphasize the importance of the cyclical nature of the operations performed by the translational machinery and thus of the relationship between initiation and the other phases of translation.
The kinetic (and thus the temporal) control of the various steps of a process as complex as translational initiation is an even more difficult problem. The apparent order of the current schemes for a major pathway is seductive but may also be misleading. There are at least three potentially serious issues. The first is that in vitro analyses of partial reactions may use conditions that distort the behavior of the translation components under study. For example, the use of an RNA-binding translation factor at excessively high ratios over the mRNA template may lead to the attribution of significant reaction rates to a process that is kinetically insignificant in vivo. Alternatively, an excess of mRNA template in an in vitro cell-free system may titrate out RNA-binding proteins that normally influence the selectivity of the translation apparatus (see, for example, reference 534). Second, reactions that may be largely temporally compartmentalized in vivo may be literally thrown together in an in vitro system, thus generating an apparently viable process that nevertheless does not accurately reflect the course of events in vivo. A hypothetical example, used here to illustrate this point, would be the role of eIF4E. Although this factor can be shown to be required for translation in a cell-free system, its major role in vivo might be restricted to the earliest stages of interaction between ribosomes and mRNA. It is not yet certain that initiation cycles on polyribosomes follow the same type of eIF4E-dependent pathway as applies to the earliest initiation events on mRNA molecules that have just left the nucleus (see also the next section). In other words, is every initiation cycle on a given mRNA mechanistically equivalent? Finally, the route followed by the translational machinery under any given conditions in the cell may be dictated by kinetic control rather than the absence of mechanistic alternatives. Thus, for example, 40S binding to the mRNA might theoretically be primarily cap mediated in vivo because of the relatively rapid kinetics of at least the initial recruitment of capped mRNA into polysomes. However, uncapped mRNA may be an acceptable alternative that is normally discriminated against on competitive kinetic grounds. These and other complications with in vitro experimental work generate uncertainties with respect to the interpretation of the resulting data.Translational Elongation and Termination
Elongation factors. The process of elongation in eukaryotic translation has generally received comparatively little attention and is assumed to function in an analogous fashion to that of its counterpart in E. coli (459). While this assumption is certainly likely to apply to the basic biochemical principles, the eukaryotic systems have their own, more complex, set of elongation factors. A highly abundant homologue of the bacterial factor EF1A (formerly called EF-Tu) is present (eEF1A). This forms a ternary complex with GTP and aminoacyl-tRNA and promotes binding of the latter to the ribosomal A site. The other eukaryotic factors (eEF1B and eEF2) do not show readily identifiable sequence homology to their prokaryotic counterparts (EF1B and EF2, formerly known as EF-Ts and EF-G, respectively). The heterotrimeric factor eEF1B catalyzes GDP-GTP exchange on eEF1A yet is dissimilar to the prokaryotic factor EF1B (EF-Ts), which performs an analogous function for EF1A. However, in yeast, eEF1B is rendered redundant if eIF1A is overexpressed (286). The other G-protein, eEF2, is thought to be required for translocation of the peptidyl-tRNA to the P site and, by analogy to the prokaryotic system, of deacylated tRNA to the E site. eEF2 is potentially a major site of regulation mediated by phosphorylation in higher cells (395, 418). An intriguing property of the eukaryotic factors eEF1A and eEF2 is their ability to bind to cytoskeletal components (36, 500), since this may provide a mechanism for the intracellular transport of mRNA, perhaps within polysomes. eIF1A and eEF2 are encoded by duplicated genes. In both cases, the encoded proteins are identical whereas there are only minimal differences in the respective reading frames (99, 394, 433).
A remarkable feature of yeasts and fungi is that they have an additional elongation factor, eEF3 (506), that is apparently absent in mammalian systems, although it does have an apparent homologue in the Chlorella virus CVU2 (604). eEF3 has a curious combination of structural features, with domains similar to ATP-binding/catalytic domains of the ATP-binding cassette (ABC) superfamily of proteins, the E. coli S5 ribosomal protein, and regions of predicted interaction with rRNA, tRNA, and mRNA (40). There is considerable uncertainty about the function of eEF3, with suggestions that it is involved in stimulating either the binding of cognate aminoacyl-tRNA to the A site (381) or the release of uncharged tRNA from the ribosomal E site (402). It remains to be seen whether the function of this factor is fulfilled by an integral component of the mammalian ribosome. For obvious reasons, eEF3 constitutes a favored target for the development of specific antifungal agents by pharmaceutical companies (201, 555).